MEDTECH : MEDTECH TO DEMONSTRATE ROSA ROBOTIC SURGERY SYSTEM AT AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS ANNUAL MEETING

information fournie par Actusnews •01/03/2016 à 14:00

Company will highlight ROSA™ Brain and recently FDA cleared ROSA™ Spine systems at largest meeting of orthopaedic surgeons

Montpellier, France, February 29, 2016 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced its participation at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, being held March 1-5 in Orlando, Florida.

The Annual Meeting is the AAOS' premier event and draws more than 30,000 participants, including Academy Fellows, members, international guests, allied health professionals, and exhibitors. During the conference, at booth #3709, Medtech will be providing hands-on demonstrations of the recently FDA cleared ROSA™ Spine system and its ROSA™ Brain system.

Bertin Nahum, CEO and Founder of Medtech, commented, “As one of the most prominent global meetings of orthopaedic surgeons, AAOS provides a significant opportunity to highlight our recently FDA cleared ROSA Spine system to potential customers from the U.S. and international markets.”

Medtech's ROSA™ robotic surgery system is designed for minimally invasive surgery. ROSA™ Brain received FDA clearance in 2012, and there are currently 31 of these systems installed in North American facilities. ROSA™ Spine received FDA clearance in January 2016. However, the robot has been in use in Europe since receiving the CE mark in 2014.